跳至主要内容
临床试验/ACTRN12621000195853
ACTRN12621000195853已完成3 期

Effect of Angiotension-II on Acute Kidney Injury after cardiac surgery - a pilot to determine feasibility of a definitive double blind randomized controlled trial (A-TRAK)

Austin Health0 个研究点目标入组 60 人开始时间: 2021年2月23日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
Austin Health
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Adult > 18 years old; Cardiac surgery using cardiopulmonary bypass including coronary artery bypass grafting (CABG) surgery, valve surgery, combined CABG/valve surgery; Elevated risk of acute kidney injury (AKI) as predicted by a score >3 on the following scale (ie. 3.5 or greater):
  • - haemoglobin < 130g/l (2 points), creatinine >100umol/l (2 points), age > 70 (1.5 points), NYHA 4 (1.5 points), BMI > 30 (1.5points)

排除标准

  • -Major aortic surgery, transplant surgery, pulmonary thrombendarterectomy, ventricular assist device placement
  • -Already receiving inotropic/vasopressor support
  • -Dialysis dependent
  • -Pre-existing uncontrolled hypertension
  • -Asthma with lung function tests demonstrating reversible airway obstruction or a history of admission to hospital with asthma exacerbations
  • -Severe LV systolic dysfunction (LVEF <30%)
  • -Significant pulmonary hypertension (ePSAP > 70mmHg, mPAP > 40mmHg)
  • -Pregnant or breastfeeding women

研究者

发起方
Austin Health

相似试验